COVID‐19 in pregnancy—what study designs can we use to assess the risk of congenital anomalies in relation to COVID‐19 disease, treatment and vaccination?

BACKGROUND: The COVID‐19 pandemic has accelerated pregnancy outcome research, but little attention has been given specifically to the risk of congenital anomalies (CA) and first trimester exposures. OBJECTIVES: We reviewed the main data sources and study designs used internationally, particularly in...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolk, Helen, Damase‐Michel, Christine, Morris, Joan K, Loane, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
SPECIAL ISSUE: INFECTIONS DURING PREGNANCY
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115419/
https://www.ncbi.nlm.nih.gov/pubmed/35234297
http://dx.doi.org/10.1111/ppe.12840

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9115419/
https://www.ncbi.nlm.nih.gov/pubmed/35234297
http://dx.doi.org/10.1111/ppe.12840

Ejemplares similares